Optometry News

FORT LAUDERDALE, Fla. — Secondary IOL implantation techniques have equivalent visual acuity results and safety profiles, along with inherent risks and postoperative complications, according to a speaker at the Retina World Congress.

Toric monofocal IOLs resulted in better uncorrected distance visual acuity and lower postoperative cylinder compared with nontoric multifocal IOLs and were more effective than corneal relaxing incisions, according to a literature review.

SEATTLE — In this Healio Video Perspective from the ARVO meeting, Michael H. Goldstein, MD, of Aurion Biotech discusses studies exploring the use of human corneal endothelial cells for corneal edema secondary to endothelial dysfunction.

NovaBay Pharmaceuticals has launched an expanded line of Avenova product bundles to provide personalized treatment options beyond artificial tears for patients with dry eye disease.

FORT LAUDERDALE, Fla. — In this Healio Video Perspective from the Retina World Congress, Carl D. Regillo, MD, discusses promising results for the Ixo-vec gene therapy for neovascular age-related macular degeneration.

FORT LAUDERDALE, Fla. — Social and political determinates of health must be addressed to provide all patients with better visual outcomes, according to a speaker at the Retina World Congress.

Male sex, Black race and insurance coverage with Medicaid were among factors associated with increased risk for developing 20/200 or worse vision among children with juvenile idiopathic arthritis-associated uveitis, according to research.

Researchers found no significant differences in keratometry measurements before cataract surgery among patients with dry eye disease vs. those without, according to a study conducted in Norway and published in Clinical Ophthalmology.

SEATTLE — In this Healio Video Perspective from the ARVO meeting, George O. Waring IV, MD, FACS, discusses the Tecnis Odyssey’s tolerance to refractive error.

SEATTLE — In this Healio Video Perspective from the Retina World Congress, David Almeida, MD, MBA, PhD, discusses combating gene therapy-associated uveitis.